Edinburgh Research Explorer

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Research output: Contribution to journalArticlepeer-review

  • Isla S Mackenzie
  • Ian Ford
  • Jesper Hallas
  • Christopher J Hawkey
  • John Webster
  • Matthew Walters
  • Michele Robertson
  • Raffaele De Caterina
  • Evelyn Findlay
  • Fernando Perez-ruiz
  • John J V Mcmurray
  • Thomas M Macdonald
  • J. Aziz
  • G. Dobson
  • A.s.f. Doney
  • R.w.v. Flynn
  • J. Furnace
  • J.w.k. Grieve
  • G. Guthrie
  • D. Jamieson
  • C.g. Jennings
  • L.c. Lund
  • A. Mcconnachie
  • F. Pigazzani
  • P.l. Riches
  • M. Rix Hanson
  • A Rogers
  • E.d.m. Rooke
  • J. Thomson
  • K. Wetherall
  • R. Wilson
  • C.p. Hall
  • A. Maseri
  • H.a. Bird
  • M. Petrie
  • M. Macdonald
  • P.s. Jhund
  • E. Connolly
  • D.j. Murphy
  • N. Paul
  • A. Olsson
  • P.t. Koskinen
  • A. Fuat
  • A. Foster
  • W. Saywood
  • R.j. Barr
  • L. Mcconnachie
  • L.f. Wilson
  • L. Larsen Rasmussen
  • A.r. Mcginnis
  • H. Birrell
  • M. Keiller
  • I.s. Bremner
  • G.j. Forbes
  • J.s. Dumbleton
  • T. Waller

Related Edinburgh Organisations

Original languageEnglish
Pages (from-to)1745-1757
JournalThe Lancet
Volume396
Issue number10264
Early online date9 Nov 2020
DOIs
Publication statusE-pub ahead of print - 9 Nov 2020

ID: 185104057